Allogene Therapeutics, Inc. Intangible Assets, Net (Excluding Goodwill)
Allogene Therapeutics, Inc. (ALLO) had Intangible Assets, Net (Excluding Goodwill) of $0 as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2021-02-25
- 2020-12-31: Intangible Assets, Net (Excluding Goodwill) $0.00.
- 2020-09-30: Intangible Assets, Net (Excluding Goodwill) $0.00.
- 2020-06-30: Intangible Assets, Net (Excluding Goodwill) $0.00.
- 2020-03-31: Intangible Assets, Net (Excluding Goodwill) $0.00.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-04 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-05 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 |
| 2019-12-31 | $151.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $301.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $452.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $603.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $754.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $904.00K 10-Q · filed 2018-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |